UK approves CRISPR gene therapy for SCD; The latest health stories from around the world
In a world first, U.K. regulators have approved a therapy that uses CRISPR, the Nobel Prize–winning gene-editing tool invented in 2012. The treatment has been shown to help people with beta thalassemia and sickle cell disease, both inherited blood disorders that involve defects in the oxygen-carrying protein haemoglobin. It relies on removing blood stem cells …
UK approves CRISPR gene therapy for SCD; The latest health stories from around the world Read More »